Combined Chlamydia and Gonorrhea Assays Achieve 98% Accuracy, Pilot Study Shows
Study revealed Lucira’s testing assays offer a 98% accuracy rate in detecting the two sexually transmitted infections.
Category: Sexually Transmitted Diseases
Sexually Transmitted Diseases
Latest
Sexually Transmitted Diseases
Latest
Visby Provides STI Diagnostic Test to Pediatric Urgent Care Provider
Visby will provide Urgent Care for Children with its Sexual Health Click Test for the detection of STIs in females 14 years of age and older.
Sexually Transmitted Diseases
Latest
Human Rights Campaign Launches National In-Home HIV Testing Kit Program
The first national in-home HIV testing program centered around reaching communities disproportionately impacted by HIV has been launched.
STIs in the Time of Covid-19
Increasing public awareness of the laboratory’s role in public health offers an opportunity to slow the spread of sexually transmitted infections.
Read More
Binx Health Inks Distribution Agreement for binx io Launch
The binx io provides results in about 30 minutes, which enables diagnosis and treatment of chlamydia and gonorrhea in a single visit.
Read More
ATCC Awarded HIV Reagent Program Contract
ATCC joins the National Institute of Allergy and Infectious Diseases’ team working on preclinical services for HIV therapeutics.
Read More
Aptima HIV-1 Quant Dx Assay Receives Additional FDA Approval for Use as an Aid in the Diagnosis of HIV Infection
Hologic’s Aptima HIV-1 Quant Dx assay is now the first dual-claim assay for both diagnosis and viral load monitoring in the United States.
Read More
Simple, Cost-Effective Molecular Assay May Help Manage Drug-Resistant Gonorrhea
A multiplex assay based on high-resolution melting technology accurately identified antimicrobial resistant determinants in Neisseria gonorrhoeae.
Read More
FDA Approves Expanded Use of CINtec Plus Cytology
CINtec Plus Cytology is a triage test based on biomarker technology for women with positive cervical cancer screening results for high-risk types of HPV.
Read More
FDA Approves Roche HIV-1/HIV-2 Qualitative Test on Cobas Systems
The test provides healthcare professionals with a single result to confirm HIV diagnosis and to differentiate HIV-1 and HIV-2.
Read More
DNA Test IDs Easily Curable Strain of Gonorrhea
UCLA researchers detected a particular genetic mutation in the gonorrhea bacterium that makes it resistant to ciprofloxacin.
Read More
USPSTF Final Recommendation on Screening for Bacterial Vaginosis to Prevent Preterm Delivery
The task force recommends against screening pregnant people for bacterial vaginosis if they are not at increased risk for preterm delivery.
Read More
Assay Detects and Differentiates Trichomonas vaginalis and Mycoplasma genitalium in Urine
The NeuMoDx TV/MG assay implemented on the NeuMoDx Molecular system allows for automated detection of T. vaginalis and M. genitalium simultaneously.
Read More
FDA Clears Simplexa VZV Swab Direct Molecular Assay
The moderate-complexity assay is designed to detect varicella-zoster virus DNA from cutaneous and mucocutaneous swab specimens.
Read More
FDA Clears Hologic Assays for Diagnosis of Vaginitis
Improved accuracy in identifying bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis will enable better targeted treatment for women.
Read More
STI Incidence on the Rise
Greater access to nucleic acid amplification tests is needed to address rising rates of extragenital chlamydia and gonorrhea.
Read More
BD Unveils New Solution for High-Throughput Molecular Diagnostic Testing
The BD Cor system automatically performs the sample preparation and processing steps necessary to complete molecular assays, while decreasing manual user interactions.
Read More
FDA Grants Breakthrough Status to Antibiotic Resistance Test for Gonorrhea
The new diagnostic test enables antibiotic resistance testing and stewardship in gonorrhea treatment.
Read More